In the information age, cancer research is shifting from data generation to bioinformatics. This interdisciplinary field develops methods and software tools for understanding biological data. Bioinformatics combines computer science, statistics, mathematics, and engineering to analyze and interpret biological data. The Cancer Prevention & Research Institute of Texas (CPRIT) recently awarded W. Jim Zheng, Ph.D., of The University of Texas Health Science Center at Houston (UTHealth) a five-year, $5.8 million grant to sort through information that could lead to cures for cancer.
Read MoreTags: Bioinformatics, cancer research, Texas Medical Center, Cancer, tmc, Biotechnology Vendor Fair, Research Funding, lab suppliers, BioResearch Product Faire, cancer therapy, Bioresearch Grant, Biotechnology trade show, 2017 research funding
The Jan and Dan Duncan Neurological Research Institute (NRI) at Texas Childrens Hospital in Houston is a leading research institution continuously making breakthroughs in the field of neurological research on topics such as autism, Alzheimer's and epilepsy. Now, thanks to Charif Souki, co-founder of Tellurian, the NRI will have an additional $10 million to further their life science research. (Image courtesy of Zereshk via Wikimedia Commons)
Read MoreTags: new research funding, tmc, BioResearch Product Faire Event, Houston, TX, Neurological Disorder, Texas Childrens Hospital, Neurological Research
The state of Texas is striving to increase cancer research capabilities and opportunities with the Cancer Prevention and Research Institute of Texas (CPRIT). One method that CPRIT uses to increase cancer research opportunities throughout the state is through the institutes core facility support awards, which provide more funding and opportunities for researchers from different Texas institutions. Recently, researchers from Texas A&M University received a $5.7 million grant from CPRIT to expand cancer research at the university through this additional core facility funding. (Image courtesy of Aggie0083 via Wikimedia Commons)
Read MoreTags: Texas A&M University, Texas Medical Center, Texas, TAMU, tmc, BioResearch Product Faire Event, Houston, TX, cancer research funding, 2018, Baylor College of Medicine, core facility funding
Does your Lab Equipment and Product Territory Include Texas?
The Texas Medical Center has recently fostered a $25 million initiative designed to support technologies and early-stage companies and to further the TMC’s mission to advance health, education and research.
"The Texas Medical Center unveiled plans for the TMC Venture Fund to an audience of more than 600 investors, hospital stakeholders, advisors and members of Houston’s innovation ecosystem" see press release. For those wondering just how big this is compared to the overall Texas Medical Center research marketplace, current estimates for the size of this market range from $1.8 Billion to $2.2 Billion.
Tags: Biotech Event, Texas Medical Center, Texas, Healthcare, tmc, Biotechnology, TX, lab equipment, Southwest Region, Biotech vendor, Lab Sales, Lab Supply, best lab supply tradeshows, best science tradeshows, BioResearch Product Faire™
In June, the Texas legislature unanimously passed Charlie’s Law which allows patients with chronic and terminal diseases access to experimental stem cell interventions. The law, named after the late Texas State representative Charlie Howard, is the first of its kind in the U.S.
Read MoreTags: Stem cell research, Human Stem Cell, Texas Medical Center, Biomedical Reearch, TAMU, tmc, Biotechnology Vendor Fair, Texas A&M Research, Texas A&M Life Science Funding, biotech vendor show, Texas A&M, Research equipment, laboratory suppliers, BioResearch Product Faire, pollution
Lymphoma is one of the most common types of cancer, with Non-Hodgkin Lymphoma making up about 4% of all cancer cases in the United States, according to the American Cancer Society. Although treatment methods like chemotherapy and radiation therapy are able to treat the cancer, researchers still actively study this cancer to gain a better understanding of it to develop new targeted treatment methods.
Researchers from the Center for Cell and Gene Therapy at Baylor College of Medicine, Texas Children's Hospital and Houston Methodist Hospital have been studying new therapies for the cancer using T-cells, research that they will continue with the assistance of a new $11.5 million grant from the National Cancer Institute. (Image courtesy of TexasPathologistMSW ia Wikimedia Commons)
Read MoreTags: new research funding, cancer research, Texas Medical Center, tmc, Houston, TX, NIH funding, 2018, Lymphoma, Baylor College of Medicine
Join Biotechnology Calendar, Inc. at the January Texas Medical Center BioResearch Product Faire Event and exhibit at the largest medical complex in the world.
With life science expenditures and NIH funding totaling more than 2.2 billion dollars , the BioResearch Product Faire™ offers an excellent opportunity to meet with well-funded researchers. This is further supported by consistent attendance at these trade shows well in excess of 400 researcher attendees, occasionally breaking 500 researchers in attendance.
Texas Medical Center has a new state of the art medical campus under construction which is estimated for completion in 2019 while the Zayed Building at MD Anderson just opend been opened in 2016. We invite you to join us early next year for Houston’s 18th Annual BioResearch Product Faire™.
Read MoreTags: cancer research, Texas Medical Center, Texas, tmc, Houston, Lab Product Sales, 2018
Researchers at Texas Medical Center’s (TCM) Houston Methodist Hospital have invented a way to overcome chemotherapy drug resistance and destroy the deadliest type of brain tumors without destroying the surrounding tissue. This targeted approach combines a “smart drug” with chemotherapy. In animal models of human brain cancer, this smart drug prolonged life by over six fold.
Read MoreTags: cancer research, Texas Medical Center, Cancer, tmc, Biotechnology Vendor Fair, cancer therapy, Bioresearch Grant, Biotechnology trade show
Researchers at Texas Medical Center’s Rice University recently discovered that Huntington’s Disease might be triggered by a repeating nucleotide sequence in the gene for a mutant protein. The research team conducted this study by analyzing proteins that were suspected to misfold and form plaques in the brains of patients with neurological diseases.
Read MoreTags: Texas Medical Center, Texas, Biotech Еvent, tmc, Biotechnology Vendor Fair, Southwest Region, Huntington's Disease
Researchers at Texas Medical Center’s McGovern School of Medicine piloted a revolutionary way of treating spina bifida patients in utero. The new method utilizes a patch made from human umbilical cord and the regenerative tissue does not cause scarring, which often leads to complications. Recent clinical trials preformed at TMC’s Fetal Center at Children’s Memorial Hermann Hospital showed improved outcomes for babies inflicted with the birth defect.
Read More
Tags: biomedical research, Texas Medical Center, tmc, Biotechnology Vendor Fair, laboratory equipment sales, spinal cord injury, McGovern Medical School, Huston, Texas, spina bifida